Open Access
Interaction of the DNA‐binding antitumor antibiotics, chromomycin and mithramycin with erythroid spectrin
Author(s) -
Majee Sangita,
Dasgupta Dipak,
Chakrabarti Abhijit
Publication year - 1999
Publication title -
european journal of biochemistry
Language(s) - English
Resource type - Journals
eISSN - 1432-1033
pISSN - 0014-2956
DOI - 10.1046/j.1432-1327.1999.00159.x
Subject(s) - spectrin , ankyrin , dna , chemistry , biochemistry , mode of action , antibiotics , cytoskeleton , biology , cell , gene
The aureolic acid group of antitumor antibiotics, chromomycin A 3 and mithramycin, are well established as transcription inhibitors, which bind reversibly to DNA at and above physiological pH, in the presence of divalent metal ions such as Mg 2+ . As part of our broad objective to elucidate their intracellular mode of action, other than association with DNA, we studied their interactions with the erythrocyte cytoskeletal protein, spectrin, in the absence and presence of magnesium. Different spectroscopic studies, such as absorbance, fluorescence and CD, have shown that both free chromomycin and mithramycin and their Mg 2+ complexes bind to spectrin with an affinity higher than that reported for DNA. The affinity constants for the association of chromomycin and mithramycin (or their Mg 2+ complexes) with spectrin are comparable with those for the association of spectrin with other cytoskeletal proteins, for example F‐actin, ankyrin, protein 4.1, etc. The nature of the binding of the two antibiotics to spectrin is different. The mode of binding of the antibiotics with spectrin also changes in the presence of Mg 2+ . The interaction leads to a change in the tertiary structure of the protein. The relevance of the results to our understanding of the mode of action of the antibiotics is discussed.